Latest Insider Transactions at Alphatec Holdings, Inc. (ATEC)
This section provides a real-time view of insider transactions for Alphatec Holdings, Inc. (ATEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alphatec Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alphatec Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
28,271
-1.94%
|
$226,168
$8.26 P/Share
|
|
May 17
2022
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
34,087
-5.55%
|
$272,696
$8.26 P/Share
|
|
May 16
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000
+25.87%
|
$16,000
$8.32 P/Share
|
|
May 13
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000
+7.97%
|
$28,000
$7.96 P/Share
|
|
May 10
2022
|
Ward W Woods Jr |
BUY
Exercise of conversion of derivative security
|
Indirect |
500,000
+23.42%
|
$1,000,000
$2.0 P/Share
|
|
May 10
2022
|
Jeffrey P Rydin |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+16.0%
|
$200,000
$2.0 P/Share
|
|
May 05
2022
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
153,634
-2.51%
|
$1,689,974
$11.01 P/Share
|
|
Apr 28
2022
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
33,517
-5.18%
|
$368,687
$11.54 P/Share
|
|
Apr 28
2022
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
16,978
-2.56%
|
$186,758
$11.54 P/Share
|
|
Apr 28
2022
|
John Todd Koning CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16,092
-5.43%
|
$177,012
$11.54 P/Share
|
|
Apr 28
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
27,488
-1.85%
|
$302,368
$11.54 P/Share
|
|
Apr 07
2022
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
67,690
-4.36%
|
$812,280
$12.99 P/Share
|
|
Apr 07
2022
|
James L L Tullis |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
251,230
+13.9%
|
$753,690
$3.5 P/Share
|
|
Apr 07
2022
|
James L L Tullis |
SELL
Open market or private sale
|
Direct |
1,630
-1.0%
|
$19,560
$12.99 P/Share
|
|
Apr 07
2022
|
James L L Tullis |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6,052
+3.58%
|
$18,156
$3.5 P/Share
|
|
Mar 18
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
66,652
-4.29%
|
$666,520
$10.94 P/Share
|
|
Mar 18
2022
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
10,582
-1.61%
|
$105,820
$10.94 P/Share
|
|
Mar 18
2022
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
5,292
-0.79%
|
$52,920
$10.94 P/Share
|
|
Mar 18
2022
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
2,940
-0.54%
|
$29,400
$10.94 P/Share
|
|
Mar 18
2022
|
John Todd Koning CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,582
-3.45%
|
$105,820
$10.94 P/Share
|
|
Mar 11
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,100
+22.77%
|
$11,000
$10.64 P/Share
|
|
Mar 08
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000
+20.0%
|
$22,000
$11.46 P/Share
|
|
Mar 08
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+2.34%
|
$22,000
$11.42 P/Share
|
|
Mar 01
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,100
-1.55%
|
$51,000
$10.94 P/Share
|
|
Feb 25
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-2.38%
|
$80,000
$10.26 P/Share
|
|
Feb 24
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-3.58%
|
$112,500
$9.44 P/Share
|
|
Feb 24
2022
|
Scott Lish CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
88,592
+11.98%
|
-
|
|
Feb 24
2022
|
Brian Snider EVP, MARKETING |
BUY
Grant, award, or other acquisition
|
Direct |
55,655
+4.07%
|
-
|
|
Feb 24
2022
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
BUY
Grant, award, or other acquisition
|
Direct |
55,655
+4.96%
|
-
|
|
Feb 24
2022
|
John Todd Koning CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
110,161
+16.62%
|
-
|
|
Feb 24
2022
|
David Sponsel EVP, SALES |
BUY
Grant, award, or other acquisition
|
Direct |
115,385
+8.42%
|
-
|
|
Feb 24
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Grant, award, or other acquisition
|
Direct |
497,531
+13.72%
|
-
|
|
Feb 24
2022
|
Patrick Miles CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,085,874
+8.12%
|
-
|
|
Feb 22
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,760
-1.8%
|
$42,840
$9.66 P/Share
|
|
Dec 16
2021
|
John Todd Koning CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+2.48%
|
$55,000
$11.17 P/Share
|
|
Dec 15
2021
|
Jason Hochberg Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.59%
|
$50,000
$10.84 P/Share
|
|
Dec 10
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
55,000
-10.46%
|
$605,000
$11.65 P/Share
|
|
Dec 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,000
+25.85%
|
$33,000
$11.66 P/Share
|
|
Dec 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.43%
|
$11,000
$11.79 P/Share
|
|
Dec 09
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
20,000
-3.66%
|
$220,000
$11.78 P/Share
|
|
Dec 09
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.49%
|
$12,000
$12.18 P/Share
|
|
Dec 02
2021
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
57,443
-1.13%
|
$574,430
$10.7 P/Share
|
|
Nov 26
2021
|
Evan Bakst |
BUY
Open market or private purchase
|
Direct |
10,000
+1.26%
|
$100,000
$10.57 P/Share
|
|
Nov 24
2021
|
Paul Segal |
BUY
Open market or private purchase
|
Direct |
100,000
+37.38%
|
$1,100,000
$11.17 P/Share
|
|
Nov 23
2021
|
Paul Segal |
BUY
Open market or private purchase
|
Direct |
67,496
+50.0%
|
$674,960
$10.09 P/Share
|
|
Nov 23
2021
|
Jason Hochberg Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.93%
|
$50,000
$10.83 P/Share
|
|
Nov 16
2021
|
David H Mowry |
SELL
Open market or private sale
|
Direct |
14,254
-15.48%
|
$171,048
$12.25 P/Share
|
|
Nov 12
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Open market or private purchase
|
Direct |
15,000
+1.4%
|
$165,000
$11.66 P/Share
|
|
Nov 12
2021
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
9,847
-1.79%
|
$108,317
$11.56 P/Share
|
|
Nov 11
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
4,366
+1.49%
|
$48,026
$11.41 P/Share
|